BIT MedTech Announces Departure of CEO

BIT MedTech has announced that CEO, Brian Kelleher, will leave the company to pursue other opportunities. BIT MedTech, based in San Diego and known previously as California MedTech and Paragon Medsystems, was acquired in 2011 by BIT Analytical Instruments. Marius Balger, CEO of BIT Analytical Instruments, will assume Kelleher’s responsibilities for the short term.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

San Diego, CA (PRWEB) July 16, 2012

BIT MedTech has announced that its current founder / CEO, Brian Kelleher, will leave the company to pursue other opportunities. In the short term, Marius Balger, CEO of BIT MedTech’s parent company, BIT Analytical Instruments, will assume Kelleher’s responsibilities.

BIT MedTech, founded in 1999 and based in San Diego, California, was known previously as California MedTech and Paragon Medsystems. The company was acquired by BIT in 2011. Says CEO, Kelleher, “It has been a very rewarding experience to have grown a successful company that has participated in developing and manufacturing so many important life science innovations.”

“On behalf of BIT, I would like to thank Mr. Kelleher for his valuable contribution to the start-up, successful growth and, most recently, the smooth and effective transition of MedTech into BIT Group,“ commented Balger. “Under Mr. Kelleher’s leadership, MedTech has grown to be a prominent player in today’s life sciences outsourcing industry. Due to the company’s proven competence and subsequent superior market position, MedTech will continue to play a pivotal role in BIT’s strategy to be the U.S. market leader in the Contract Services Provider segment for complex medical and IVD instrumentation. With further investment in services, technology and platform solutions, we look forward to taking the San Diego operation to the next level” said Mr. Balger, “We wish Mr. Kelleher the best of luck with his future opportunities and will continue to interact with him as we move forward with our growth strategies.”

“I am confident that MedTech will continue to prosper under the BIT leadership,” Kelleher added, “the synergies between MedTech and the other divisions of BIT are starting to have a meaningful impact, and ultimately will create a compelling value proposition for life science companies interested in outsourcing to a proactive, technology-focused partner.”

For over 35 years BIT Companies (http://www.BIT-Companies.com) have provided services in the field of contract development and manufacturing as well as after-sales service for customers in the fields of medical, diagnostics, life science, and biotechnology. As a part of the financially strong Messer World, BIT Companies provide their systems solutions worldwide and in compliance with ISO 13485 and 9001 standards. As registered contract service providers to the FDA, BIT Companies meet the stringent regulations with regard to medical and complex medical technical products while simultaneously adhering to predefined design-to-cost and time-to-market targets.

BIT Companies (http://www.BIT-Companies.com) include BIT Medtech in San Diego, CA, USA; Source Scientific, LLC in Irvine, California, USA; BIT Analytical Instruments Ltd.in Ludlow, Massachusetts USA; BIT Analytical Instruments GmbH in Schwalbach, Germany; BIT Technologies in Kunshan, China; BIT Japan Ltd. in Tokyo Japan; and BIT C2 Diagnostics in Montpellier, France.